Literature DB >> 10858649

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.

A P Plaisier1, W A Stolk, G J van Oortmarssen, J D Habbema.   

Abstract

Using estimates for the anthelmintic efficacy of a single dose of ivermectin in the treatment of lymphatic filariasis patients, Anton Plaisier, Wilma Stolk, Gerrit van Oortmarssen and Dik Habbema here present and discuss model predictions of the impact of a five-year programme of annual community treatment on the intensity of infection. They show that the effectiveness of such programmes in terms of reductions in the microfilarial density depends critically on the treatment coverage and the pattern of attendance at repeated mass administrations. Improving these factors will possibly be more important than improving the efficacy of ivermectin by increasing its dosage or by adding other drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858649     DOI: 10.1016/s0169-4758(00)01691-4

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  25 in total

1.  Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.

Authors:  Achim Hoerauf; Sabine Mand; Kerstin Fischer; Thomas Kruppa; Yeboah Marfo-Debrekyei; Alexander Yaw Debrah; Kenneth M Pfarr; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

2.  Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Authors:  Paul E Simonsen; Erling M Pedersen; Rwehumbiza T Rwegoshora; Mwelecele N Malecela; Yahya A Derua; Stephen M Magesa
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

Review 3.  Ivermectin: a complimentary weapon against the spread of malaria?

Authors:  Haoues Alout; Brian D Foy
Journal:  Expert Rev Anti Infect Ther       Date:  2016-12-29       Impact factor: 5.091

4.  Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.

Authors:  Brajendra K Singh; Moses J Bockarie; Manoj Gambhir; Peter M Siba; Daniel J Tisch; James Kazura; Edwin Michael
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.

Authors:  Wilma A Stolk; Sake J de Vlas; J Dik F Habbema
Journal:  Filaria J       Date:  2006-03-28

6.  Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.

Authors:  Hugues C Nana-Djeunga; Jules B Tchatchueng-Mbougua; Jean Bopda; Steve Mbickmen-Tchana; Nathalie Elong-Kana; Etienne Nnomzo'o; Julie Akame; Ann Tarini; Yaobi Zhang; Flobert Njiokou; Joseph Kamgno
Journal:  PLoS Negl Trop Dis       Date:  2015-09-09

7.  Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

Authors:  Wilma A Stolk; Quirine A ten Bosch; Sake J de Vlas; Peter U Fischer; Gary J Weil; Ann S Goldman
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03

8.  The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.

Authors:  Doris W Njomo; Mary Amuyunzu-Nyamongo; Japheth K Magambo; Sammy M Njenga
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.

Authors:  Richard D Rheingans; Anne C Haddix; Mark L Messonnier; Martin Meltzer; Gladys Mayard; David G Addiss
Journal:  Filaria J       Date:  2004-01-30

10.  Maternal Infection Is a Risk Factor for Early Childhood Infection in Filariasis.

Authors:  Madhusmita Bal; Prakash K Sahu; Nityananda Mandal; Ashok K Satapathy; Manoranjan Ranjit; Shatanu K Kar
Journal:  PLoS Negl Trop Dis       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.